Almost 70 years after the discovery of the respiratory syncytial virus (RSV), vaccines and preventive treatments are giving babies a chance to beat the potentially deadly childhood infection.

About 8 in 10 infants received respiratory syncytial virus protection during the 2023 to 2024 season, according to study findings.

Respiratory Syncytial Virus (RSV) is a highly contagious respiratory illness that primarily affects infants and older adults, ...

said RSV is a seasonal infection and they see a lot of patients between November and February every year, but this winter has ...

At the start of every week, our team talks with local experts to unpack a wide range of nationwide health, safety, and ...

Respiratory syncytial virus (RSV) leads to over 30 million severe respiratory infections, 3.5 million hospitalizations, and 100,000 deaths among children under five each year globally. Nearly half of ...

For most people RSV is like a cold, but for infants and older people it can lead to serious infections. Here's what to know.

Three-quarters of infants were exposed to the maternal RSV vaccine or nirsevimab during their first RSV season. Younger mothers and Black mothers were less likely to receive the maternal vaccine.

The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels of flu and RSV activity in wastewater. In emergency room visits, the CDC ...

It spreads through inhalation or contact with the fluids from an infected person's coughs or sneezes. 2 While often linked to ...

If you’re feeling under the weather, chances are pretty high that you have one of four popular viruses going around: influenza A (the flu), COVID-19, norovirus (the stomach flu) and respiratory ...